Nuances in Treating Advanced Lung Adenocarcinoma

EP. 1: Upfront Immunotherapy for PD-L1+ NSCLC

June 23rd 2017

EP. 2: Update on PD-L1 Testing for NSCLC

June 23rd 2017

EP. 3: Checkpoint Inhibitors for Relapsed or Refractory NSCLC

June 23rd 2017

EP. 4: Combined Immunotherapy and Chemotherapy for NSCLC

June 23rd 2017

EP. 5: The Current Role for Antiangiogenic Therapy for NSCLC

June 23rd 2017

EP. 6: Late-Stage Trials: Immunotherapy Combinations for NSCLC

June 23rd 2017

EP. 7: Novel Trials of Immunotherapy Combinations for NSCLC

June 23rd 2017

EP. 8: The Potential for Adjuvant Immunotherapy for NSCLC

June 23rd 2017

EP. 9: Treatment of Metastatic EGFR-Positive NSCLC

June 23rd 2017

EP. 10: Emerging Options for Treatment of EGFR-Positive NSCLC

June 23rd 2017

EP. 11: Evolving Approaches for Treating ALK-Positive NSCLC

June 23rd 2017

EP. 12: Future Directions for Treatment of Lung Adenocarcinoma

June 23rd 2017